Abstract:Sensorineural hearing loss often results from damaged or deficient inner ear hair cells. Mitochondrial 12S rRNA 1555A>G mutation has been associated with hearing loss in many families. The m.1555A>G mutation is a primary factor underlying the development of hearing loss and TRMU allele (c.28G>T, p.Ala10Sser) encoding tRNA thiouridylase interact with m.1555A>G mutation to cause hearing loss. However, the tissue specificity of mitochondrial dysfunction remains elusive and there is no highly effective therapy for mitochondrial deafness. We report here the generation of induced pluripotent stem cells (iPSCs) from lymphoblastoid cell lines derived from members of an Arab-Israeli family (asymptomatic individual carrying only m.1555A>G mutation, symptomatic individual bearing both m.1555A>G and c.28G>T mutations, and control subject). The c.28G>T mutation in iPSC lines from a hearing-impaired subject was corrected by CRISPR/Cas9. These iPSCs were differentiated into otic epithelial progenitor (OEP) cells and subsequent inner ear hair cell (HC)-like cells. The iPSCs bearing m.1555A>G mutation exhibited mildly deficient differentiation into OEP and resultant HC-like cells displayed mild defects in morphology and electrophysiological properties. Strikingly, those HC-like cells harboring m.1555A>G and TRMU c.28G>T mutations displayed greater defects in the development, morphology and functions than those in cells bearing only m.1555A>G mutation. Transcriptome analysis of patients-derived HC-like cells revealed altered expressions of genes vital for mechanotransduction of hair cells. Genetic correction of TRMU c.28G>T mutation yielded morphologic and functional recovery of patient derived HC-like cells. These findings provide new insights into pathophysiology of maternally inherited hearing loss and a step toward therapeutic interventions for this disease.

Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders

Genetic Correction of TRMU Allele Restored the Mitochondrial Dysfunction-Induced Deficiencies in Ipscs-Derived Hair Cells of Hearing-Impaired Patients.

Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice

Tmc gene therapy restores auditory function in deaf mice

Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness

AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration

Virally Mediated Kcnq1 Gene Replacement Therapy in the Immature Scala Media Restores Hearing in A Mouse Model of Human Jervell and Lange-Nielsen Deafness Syndrome

Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction

Genetic correction of induced pluripotent stem cells from a DFNA36 patient results in morphologic and functional recovery of derived hair cell-like cells

Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction

Extended time frame for restoring inner ear function through gene therapy in Usher1G preclinical model

[Study on Gene Therapy for DPOAE and ABR Threshold Changes in Adult Otof-/- Mice].

Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness

Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness

Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8

Hair Cell-specific Myo15 Promoter-mediated Gene Therapy Rescues Hearing in DFNB9 Mouse Model

Approaches and Vectors for Efficient Cochlear Gene Transfer in Adult Mouse Models

Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction

Gene therapy: an emerging therapy for hair cells regeneration in the cochlea

AAV2.7m8 is a powerful viral vector for inner ear gene therapy

Milestones toward cochlear gene therapy for patients with hereditary hearing loss